Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.5900
+0.0500 (9.26%)
At close: Jan 16, 2026
Protagenic Therapeutics Company Description
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.
Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Protagenic Therapeutics, Inc.
| Country | United States |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
Contact Details
Address: 701 Anacapa Street Santa Barbara, California 93101 United States | |
| Phone | (805) 699-5596 |
| Website | phytanix.com |
Stock Details
| Ticker Symbol | PTIX |
| Exchange | OTCMKTS |
| Reporting Currency | USD |
| ISIN Number | US74365N1037 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Garo H. Armen Ph.D. | Executive Chairman |
| Dr. Alexander Kenneth Arrow C.F.A., M.D. | Chief Financial Officer |
| Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer |